Context

Mild Cognitive Impairment (MCI) is a transitional stage between normal aging and dementia, yet underdiagnosis remains a challenge due to the variability of symptoms. Vascular MCI, the most prevalent subtype in Asia, is strongly associated with hypertension, diabetes, and hyperlipidemia—risk factors affecting 500 million individuals across the region.

• 10-15% of MCI patients progress to dementia annually

• Early detection enables proactive intervention and care

A Singapore-based startup has developed an AI-powered digital tool to provide fast, reliable, and accessible screening for Vascular MCI.

• Rapid Detection – Clinically validated cognitive games detect MCI within 10 to 15 minutes

• Personalized Dashboards – AI-generated reports guide clinicians and patients in treatment planning

• Subtype Differentiation – Ensures targeted interventions for improved patient outcomes

By integrating neuroscience, AI, and digital health technology, this platform enhances cognitive health assessments for healthcare professionals and the general population.

VentureBlick is involved in a preliminary study to help the company ascertain its potential in the European markets, specifically Germany. Selected advisors will not be identified individually – only their country and specialty will be made known.

Experts Needed

·   Experts from Germany

·   Medical expert specialties: Neurologists, Primary Care, Clinical Research (MCI Research Focus)

·   Industry expert specialties: Reimbursement, Regulatory, Commercialisation

Advisors should have at least 10 years of experience in their respective fields.

Work Required

·   Interview Preparation: Read concise company backgrounder to familiarize yourself with companies' product

·   Interview: Participate in a 1-hour structured interview

Note

If your expertise aligns with this project, we encourage you to apply for consideration. Due to expected high interest, only shortlisted advisors will be contacted for follow-ups.

For specific questions regarding eligibility or other inquiries, please reach out via the contact details below